Evidence map›Paper›PMID 37564639›Full record

ArticleFrontiers in immunology2023

Specific attributes of the V

Bora Guloglu, Charlotte M Deane

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bora GulogluOxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, United Kingdom.
Charlotte M DeaneOxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, United Kingdom.
University of Oxford · GB

Funding

WellcomeTrus
6 · The paper itself

Abstract

Antibodies, through their ability to target virtually any epitope, play a key role in driving the adaptive immune response in jawed vertebrates. The binding domains of standard antibodies are their variable light (V

Indexed as

Complementarity Determining RegionsImmunoglobulin Light ChainsAnimalsHumansImmunoglobulin Heavy ChainsMolecular Dynamics SimulationProtein ConformationComplementarity Determining RegionsImmunoglobulin Heavy ChainsImmunoglobulin Light Chainsantibody designantibody dynamicsCDR-H3loop dynamicsparatopestructural modeling

Identifiers

PMID37564639
PMCPMC10410447
OpenAlexW4385272068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.